Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STANDARD BIOTOOLS INC. Delisting Announcement 2017

Aug 2, 2017

32853_dlst_2017-08-02_11d2b0de-4d4d-4bd6-a195-1030120c783b.zip

Delisting Announcement

Open in viewer

Opens in your device viewer

25 1 t1702258_25.htm FORM 25

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 25

NOTIFICATION OF REMOVAL FROM LISTING AND/OR

REGISTRATION UNDER SECTION 12(b) OF THE

SECURITIES EXCHANGE ACT OF 1934.

Commission File Number

001-34180

Field: Rule-Page

Field: /Rule-Page

Fluidigm Corporation

The Nasdaq Global Select Market

Field: Rule-Page

Field: /Rule-Page

(Exact name of Issuer as specified in its charter, and name of Exchange where security is listed and/or registered)

7000 Shoreline Court, Suite 100

South San Francisco, California 94080

(650) 266-6000

Field: Rule-Page

Field: /Rule-Page

(Address, including zip code, and telephone number, including area code, of Issuer's principal executive offices)

Preferred Share Purchase Rights

Field: Rule-Page

Field: /Rule-Page

(Description of class of securities)

Please place an X in the box to designate the rule provision relied upon to strike the class of securities from listing and registration:

¨ 17 CFR 240.12d2-2(a)(1)

¨ 17 CFR 240.12d2-2(a)(2)

¨ 17 CFR 240.12d2-2(a)(3)

¨ 17 CFR 240.12d2-2(a)(4)

¨ Pursuant to 17 CFR 240.12d2-2(b), the Exchange has complied with its rules to strike the class of securities from listing and/or withdraw registration on the Exchange. 1

x Pursuant to 17 CFR 240.12d2-2(c), the Issuer has complied with the rules of the Exchange and the requirements of 17 CFR 240.12d2-2(c) governing the voluntary withdrawal of the class of securities from listing and registration on the Exchange.

Pursuant to the requirements of the Securities Exchange Act of 1934, Fluidigm Corporation certifies that it has reasonable grounds to believe that it meets all of the requirements for filing the Form 25 and has caused this notification to be signed on its behalf by the undersigned duly authorized person.

August 2, 2017 /s/ Stephen Christopher Linthwaite President and Chief Executive Officer
Date Name Title

Field: Rule-Page

Field: /Rule-Page

1 Form 25 and attached notice will be considered compliance with the provisions of 17 CFR 240.19d-1 as applicable. See General Instructions.

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1; Options: Last

Field: /Page